Abstract:Metal-organic frameworks (MOFs), which are typically embedded in polymer matrices as composites, are emerging as a new class of carriers for sustained drug delivery. Most of the MOFs and the polymers used so far in these composites, however, are not pharmaceutically acceptable. In the investigation reported herein, composites of γ-cyclodextrin (γ-CD)-based MOFs (CD-MOFs) and polyacrylic acid (PAA) were prepared by a solid in oil-in-oil (s/o/o) emulsifying solvent evaporation method. A modified hydrothermal protocol has been established which produces efficiently at 50 °C in 6 h micron (5-10 μm) and nanometer (500-700 nm) diameter CD-MOF particles of uniform size with smooth surfaces and powder X-ray diffraction patterns that are identical with those reported in the literature. Ibuprofen (IBU) and Lansoprazole (LPZ), both insoluble in water and lacking in stability, were entrapped with high drug loading in nanometer-sized CD-MOFs by co-crystallisation (that is more effective than impregnation) without causing MOF crystal degradation during the loading process. On account of the good dispersion of drug-loaded CD-MOF nanocrystals inside polyacrylic acid (PAA) matrices and the homogeneous distribution of the drug molecules within these crystals, the composite microspheres exhibit not only spherical shapes and sustained drug release over a prolonged period of time, but they also demonstrate reduced cell toxicity. The cumulative release rate for IBU (and LPZ) follows the trend: IBU-γ-CD complex microspheres (ca. 80% in 2 h) > IBU microspheres > IBU-CD-MOF/PAA composite microspheres (ca. 50% in 24 h). Importantly, no burst release of IBU (and LPZ) was observed from the CD-MOF/PAA composite microspheres, suggesting an even distribution of the drug as well as strong drug carrier interactions inside the CD-MOF. In summary, these composite microspheres, composed of CD-MOF nanocrystals embedded in a biocompatible polymer (PAA) matrix, constitute an efficient and pharmaceutically acceptable MOF-based carrier for sustained drug release.

A parametric study of lumped circuit parameters of a miniature planar spiral transformer

Controlled Zn2+-Triggered Drug Release by Preferred Coordination of Open Active Sites Within Functionalization Indium Metal Organic Frameworks.

Dual-Stimulus-Triggered Programmable Drug Release and Luminescent Ratiometric Ph Sensing from Chemically Stable Biocompatible Zinc Metal-Organic Framework.

Preparation and Biological Characterization of Hollow Magnetic Fe3O4@C Nanoparticles As Drug Carriers with High Drug Loading Capability, Ph-Control Drug Release and MRI Properties

CD-MOFs: From preparation to drug delivery and therapeutic application

Cyclodextrin-based metal-organic frameworks transforming drug delivery

Composite CD-MOF Nanocrystals-Containing Microspheres for Sustained Drug Delivery

Cellular adhesion and proliferative responses of neonatal human lymphocytes to pig endothelial cells.

PEGylated chitosan decorated UiO-66 nanoscale metal–organic frameworks as promising carriers for drug delivery

A Low Cytotoxic Cationic Metal-Organic Framework Carrier for Controllable Drug Release

Cyclodextrin-Based Metal-Organic Frameworks (CD-MOFs) in Pharmaceutics and Biomedicine

Cyclodextrin-based Metal-Organic Frameworks for Pulmonary Delivery of Curcumin with Improved Solubility and Fine Aerodynamic Performance.

Cyclodextrin-based metal-organic framework materials: Classifications, synthesis strategies and applications in variegated delivery systems

Submitochondrial localization and partial purification of the succinylCoA: 3-hydroxy-3-methylglutarate coenzyme A transferase from rat liver.

A γ-cyclodextrin-based metal–organic framework (γ-CD-MOF): a review of recent advances for drug delivery application

Defective MOFs as nano carrier for drug loading with controlled release

Simultaneous solubilization and extended release of insoluble drug as payload in highly soluble particles of γ-cyclodextrin metal-organic frameworks

Small Titanium-Based MOFs Prepared with the Introduction of Tetraethyl Orthosilicate and Their Potential for Use in Drug Delivery

New method for modeling nonlinear hyperbolic concentrators

Novel formulations of metal-organic frameworks for controlled drug delivery

Nanoscale Iron-Based Metal-Organic Frameworks: Incorporation of Functionalized Drugs and Degradation in Biological Media